Similarly, Li and colleagues have demonstrated that the expression of KRT7 is significantly and positively associated with four common immune checkpoints, namely TGFB1 (Transforming Growth Factor Beta 1)/CED, Nectin-2 (PVRL2), and NT5E (CD73) in patients diagnosed with adenocarcinoma of the pancreas (6). The gene discussed is KRT7; the disease is pancreatic adenocarcinoma.